Forefront Analytics’s Surface Oncology SURF Stock Holding History
Bought
Maintained
Sold
Other funds holding SURF
Forefront Analytics's SURF Position: Q2 2023 in Review
Forefront Analytics sold out of Surface Oncology (SURF) in Q2 2023, closing a stake of 61,156 shares — an estimated $42.7K sold.
Forefront Analytics first reported a position in SURF in Q1 2022 and held it in 5 quarters. The position peaked at $71K in Q2 2022. 61 funds tracked by Wall St. Rank hold SURF as of Q2 2023.
- Forefront Analytics reported no remaining Surface Oncology position as of Q2 2023 after selling out during the quarter.
- Forefront Analytics sold 61,156 Surface Oncology shares in Q2 2023, an estimated $42.7K.
- Forefront Analytics first reported a position in Surface Oncology in Q1 2022 and held it in 5 quarters.
- Forefront Analytics's Surface Oncology position peaked at $71K in Q2 2022.
- 61 funds tracked by Wall St. Rank held Surface Oncology as of Q2 2023.
Based on Forefront Analytics's 13F filing for Q2 2023, filed 11 Aug 2023.